Stem cell promises gets ahead of science

09/12/2013 | New York Times (tiered subscription model), The

Numerous clinics offer stem cell treatments for conditions such as lung disease and spinal cord injuries, but scientists have proven neither the efficacy nor safety of these treatments. Stem cell scientists worry that the marketing of unproven, unregulated products and treatments will undermine the legitimacy of their research. A statement from the International Society for Stem Cell Research says the nonscientific use of stem cells represents "a threat to patient welfare, patient autonomy and to the scientific process."

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ